Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

advanced medical optics, inc. (amo) - sulfasalazine - tablet - 500 mg

Namibia - English - Namibia Medicines Regulatory Council

pfizer laboratories (pty) ltd - sulphasalazine - tablets - sulphasalazine tablet 500mg

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - sulfasalazine 500 mg - gastro-resistant tablet - 500 mg - sulfasalazine 500 mg - sulfasalazine

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer limited - sulfasalazine - tablets - 500 milligram - aminosalicylic acid and similar agents

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - sulfasalazine - tablet - 500 milligram(s) - aminosalicylic acid and similar agents; sulfasalazine

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pfizer laboratories (pty) ltd - tablet - see ingredients - each tablet contains sulphasalazine 500 mg

Kenya - English - Pharmacy and Poisons Board

pfizer laboratories limited 197 lenana road - nairobi - sulfasalazine - tablet - 500mg - intestinal anti-inflammatory agents:

Canada - English - Health Canada

pfizer canada ulc - sulfasalazine - tablet - 500mg - sulfasalazine 500mg - sulfonamides

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - azathioprine, quantity: 50 mg - tablet, film coated - excipient ingredients: lactose monohydrate; pregelatinised maize starch; magnesium stearate; maize starch; macrogol 400; stearic acid; hypromellose - indicatins as at 2 febuary 2005 : thioprine is used as an immunosuppressant antimetabolite either alone, or more commonly in combination with other agents (usually corticosteroids) and procedures which influence the immune response. therapeutic effect may be evident only after weeks or months and can include a steroid-sparing effect, thereby reducing the toxicity associated with high dosage and prolonged usage of corticosteroids. thioprine, in combination with corticosteroids and/or other immunosuppressive agents and procedures, is indicated in the management of patients receiving organ transplants. thioprine, either alone or more usually in combination with corticosteroids and/or other procedures, has been used with clinical benefit which may include reduction of dosage or discontinuation of corticosteroids, in a proportion of patients suffering from the following; severe rheumatoid arthritis; systemic lupus erythematosus; dermatomyositis/polymyositis; autoimmune chronic active hepatitis; pemphigus vulgaris

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - sulfasalazine - oral tablet - 500mg